ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dikmen, E.
Right arrow Articles by Sakinci, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dikmen, E.
Right arrow Articles by Sakinci, U.
Eur Respir J 2006; 27:73-76
Copyright ©ERS Journals Ltd 2006

Human hepatocyte growth factor levels in patients undergoing thoracic operations

E. Dikmen1, M. Kara1, U. Kisa2, C. Atinkaya1, S. Han3 and U. Sakinci3

1 Depts of Thoracic Surgery, and 2 Biochemistry, University of Kirikkale, School of Medicine, Kirikkale, and 3 Dept of Thoracic Surgery, Numune Education and Research Hospital, Ankara, Turkey.

CORRESPONDENCE: E. Dikmen, Bulbulderesi caddesi 65/8, TR-06660, Kucukesat, Ankara, Turkey. Fax: 90 3182252819. E-mail: dikmenerkan{at}hotmail.com

Keywords: Hepatocyte growth factor, pulmonary resection, surgery

Received: December 28, 2004
Accepted August 6, 2005

Human hepatocyte growth factor (hHGF) is the most potent mitogen identified for alveolar type II cells, and may have other important functions in the repair of the alveolar epithelium and compensatory lung growth. A study was conducted to evaluate the changes of serum hHGF levels in patients who underwent thoracic surgical procedures.

The patients comprised 17 males and 14 females with a mean age of 47.1±13.5 yrs, who underwent either lung resection (LR group) or nonlung resection (nonLR group) thoracic procedures. The changes of hHGF levels were analysed in the pre- and post-operative periods in both groups.

The pre-operative hHGF levels did not differ between the LR and the nonLR groups, which were 333.2±72.9 pg·mL–1 and 343.6±125.3 pg·mL–1, respectively. The hHGF levels in the LR group significantly increased up to 433.6±128.1 pg·mL–1 and 430.8±128.2 pg·mL–1 in post-operative days 1 and 3, respectively. However, the same levels in the nonLR group appeared as 333.2±77.0 pg·mL–1 and 311.9±73.0 pg·mL–1, respectively.

In conclusion, the increases of serum human hepatocyte growth factor levels following pulmonary resection may imply the important role of human hepatocyte growth factor in lung regeneration or compensatory lung growth in humans.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.